Cancer Vaccines Market Research Report 2020
The Cancer Vaccines Market is expected togrow at a CAGR of 14% from 2020-2030, according to a new research report by NextMove Strategy Consulting
A vaccine is a biologicalpreparation that is introduced in human body in order to acquire immunityagainst diseases. Cancer is a chronic disorder that leads to uncontrolled cellgrowth & conquer other tissues in the body. Cancer vaccine is speciallydesigned to increase immunity in human body against cancer by creatingantibodies against them. These antibodies then recognize the cancer cells andsuppress its growth.
According to the report, thehigh prevalence rate of cancer and growth in human papilloma virus (HPV)infections are the major factors driving the market growth. Also, surge inresearch & development activities owing to the growth in market investmentsled to the launch of new vaccines. Furthermore, rising awareness among peoplealong with surge in vaccination as well as growth in government initiatives topromote vaccination are also expected to gain traction. Moreover, developmentin healthcare facilities supported by the government funding & highinvestments for the development of new cancer vaccines is also expected toamplify the market growth. Other factors such as huge product pipeline andrising demand for cancer vaccines can change the market trends.
However, high cost of cancervaccines owing to the high R&D cost and stringent regulatory process forapproval is likely to inhibit the market growth. Moreover, rising demand fortherapeutic vaccines and increasing approval of new vaccines are expected to providenumerous opportunities to the market players in the coming few years.
On the basis of technology, thecancer vaccines market share is segmented into subunit vaccines, conjugatevaccines, inactivated vaccines, live attenuated vaccines, and recombinantvector vaccines. Recombinant vectors vaccine holds the major market share inthe cancer vaccine market and is expected to dominate the market throughout theforecast period.
On the basis of treatmentmethod, the cancer vaccines market is categorised into preventive vaccine andtherapeutic vaccine. Preventive vaccine holds the major market share and isexpected to dominate the market growth.
On the basis of indication, thecancer vaccine market is fragmented into prostate cancer, liver cancer,cervical cancer, skin cancer, and others. Prostate cancer is expected todevelop significantly over the period of time and is likely to dominate themarket among all other indication types.
On the basis of end user, themarket is bifurcated into adult vaccines and paediatric vaccine. The adultvaccines segment is likely to develop at a significant growth rate owing tohigh prevalence rate in adults.
North America dominates thecancer vaccine market in terms of market share & size over the forecastperiod owing to the presence of developed healthcare facilities &infrastructure and rising number of cancer patients. In addition, surge inresearch & development activities along with increasing approvals for newcancer vaccines are expected to contribute market growth. Europe accounts forthe second leading position in the cancer vaccines market in terms of market size.Asia Pacific is expected to be the fastest developing region in the cancervaccines market, majorly driven by the high government funding for thedevelopment of new vaccines. Moreover, rising prevalence of cancer and growthin HPV infections are also expected to promote the market growth.
According to the report, some the keyplayers in the cancer vaccines market are CSL Limited, Pfizer Inc.,Bristol-Myers Squibb, Astrazeneca Plc., Sanofi Pasteur, AduroBioTech Inc.,Sanpower Group, Glaxosmithkline Plc., Merck & Co., Inc., AstellasPharma Inc.
Browse keyindustry insights from the report, “Cancer Vaccines Market Size By Technology (Subunit Vaccines, ConjugateVaccines, Inactivated Vaccines, Live Attenuated Vaccines, and RecombinantVector Vaccines) By Treatment Method (Preventive Vaccine and TherapeuticVaccine), By Indication (Prostate Cancer, Liver Cancer, Cervical Cancer, SkinCancer, and Others), By End User (Adult Vaccines and Paediatric Vaccine)RegionalOutlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, China, India,Japan, Australia, Indonesia, Malaysia, South Korea, Brazil, Mexico, SouthAfrica, Saudi Arabia, UAE, Kuwait), Growth Potential, Price Trends, CompetitiveMarket Share & Forecast, 2020–2030” in detail along with the tableof contents:
Key Insights from the CancerVaccines Market Report:
- Asia Pacific is the fastest growing region in the Cancer Vaccines market owing to the rising prevalence of cancer, growth in HPV infections and high government funding for the development of new vaccine.
· The prostate cancer segments dominatesthe market in terms of indication and is expected to grow at a significant CAGRto maintain the lead till 2030.
- Some of the major players in the market are CSL Limited, Pfizer Inc., Bristol-Myers Squibb, Astrazeneca Plc., Sanofi Pasteur, Aduro BioTech Inc., Sanpower Group, Glaxosmithkline Plc., Merck & Co., Inc., Astellas Pharma Inc.
The report Cancer Vaccines market – segmented by technology, treatmentmethod, indication, end user and geography
Get a free sample on the Cancer Vaccines Marketreports
About Next Move Strategy Consulting
NextMove Strategy Consulting is an independent and trusted third-platform marketintelligence provider, committed to deliver high quality, market researchreports that help multinational companies to triumph over their competitionsand increase industry footprint by capturing greater market share. Our researchmodel is a unique collaboration of primary research, secondary research, datamining and data analytics.
Wehave been servicing over 1000 customers globally that includes 90% of theFortune 500 companies over a decade. Our analysts are constantly trackingvarious high growth markets and identifying hidden opportunities in each sectoror the industry. We provide one of the industry’s best quality syndicate aswell as custom research reports across 10 different industry verticals. We arecommitted to deliver high quality research solutions in accordance to yourbusiness needs. Our industry standard delivery solutions that ranges from thepre consultation to after-sales services, provide an excellent clientexperience and ensure right strategic decision making for businesses.
For more insights, please visit, https://www.nextmsc.com
